Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis.
about
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceTransformative tools for tackling tuberculosisHIV and tuberculosis--science and implementation to turn the tide and reduce deathsIncidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysisPredictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control studyScreening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective studyDetection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control studyImpact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa.The Bandim TBscore--reliability, further development, and evaluation of potential uses.Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis.Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuriaPrevalence of national treatment algorithm defined smear positive pulmonary tuberculosis in HIV positive patients in Brazzaville, Republic of CongoPoint-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays.Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008.State of affairs of tuberculosis in prison facilities: a systematic review of screening practices and recommendations for best TB controlIncidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.PEPFAR support for the scaling up of collaborative TB/HIV activitiesDetermine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studiesA Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers.Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcomeRapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa.Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana-findings from the DETECT HIV-TB study.Underestimation of the True Specificity of the Urine Lipoarabinomannan Point-of-Care Diagnostic Assay for HIV-Associated TuberculosisCharacteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapyDiagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive studyThe health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States.High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay.Correlates of Delayed Diagnosis among Human Immunodeficiency Virus-Infected Pulmonary Tuberculosis Suspects in a Rural HIV Clinic, South Africa.Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya.Are HIV-positive presumptive tuberculosis patients without tuberculosis getting the care they need in Zimbabwe?Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assayAdvances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care testDiagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe.Increased sensitivity in diagnosis of tuberculosis in HIV-positive patients through the small-membrane-filter method of microscopy.Characteristics of adults and children diagnosed with tuberculosis in Lilongwe, Malawi: findings from an integrated HIV/TB clinic
P2860
Q22241307-1FF26D48-0EAA-4105-811B-336D8BD0C942Q26784084-846CEB28-2896-43F3-9186-F8BFC6D5A3E2Q26824501-45C38D3B-31A8-4F4D-A4B7-62CF032C1E30Q27012753-31F8C055-B5F1-4AA6-A62A-5CFBD32F3E71Q28397102-41FB0AAF-E4B0-47CD-9BAD-668256D81141Q28479309-B771C15C-033C-4A41-96ED-F621571B6915Q28662246-7C10D5F0-DA48-4EC5-B3E9-D411B8F4082EQ30653441-E56DCB4D-A55F-428D-827A-04AECCCFBEABQ33655933-FEBD6446-91E6-4A31-AC76-8D83A069505BQ33975232-206B4486-D38B-4AE7-B1C4-D936F115C818Q34173643-1B97B236-C53B-41E5-A3EB-135ABCA20F81Q34203557-960B87F4-7456-4EC1-9960-FDBAE35C5B74Q34247819-CAB92BFF-2CB7-4AE8-AC5A-2479E3F85867Q34340867-F9832E6B-DD7E-4D11-B08D-0486F507F923Q34438327-21B83995-B9AE-406E-BE09-7AA328D6267FQ34455442-24CADB85-FF76-480A-BEF3-C20300C5615FQ34509326-4B4AEB08-AD4C-45C4-8D8A-2C06EF305A13Q34542267-2272C2D2-1F4F-4605-855F-CC3EB6782905Q34563388-183E7946-2616-488C-9686-5342AE7FADFDQ34570912-B1390D7F-2A7A-418A-9F67-4A5BECE8C27AQ34675209-152EE0DC-99DB-4968-BD89-8549E9302ECBQ34785461-21A38A5B-9BD7-4EB8-A9E1-6B45608ACEA4Q34978276-D4CB1D63-4845-45C4-8CF2-BEFC87D4FCD9Q35072083-41BE768E-3AB2-4AF1-A449-11F4951000A6Q35075811-11202172-BEEB-4088-B1FE-442FA1F7F214Q35746807-87C69E6E-3984-4FF4-9F75-041599E91F99Q35795483-84D24A68-9586-44E7-8601-C939D57C8D22Q35801370-FFA67586-A710-4997-B4A8-5DA003D936D4Q35845327-B99076E4-17F0-4102-9D15-8A23B06A44A7Q35859708-E46A56C2-3015-4D3C-B9F8-1F1B4E3D8D56Q36051570-BBF55DF9-1B35-4313-B288-19CED5BFDC25Q36062867-E4509CA6-7B32-447E-8616-DB60E82800C2Q36063396-F4CB91BE-A26E-4FAB-B271-C7B1CDDF3F1AQ36218341-06A11C57-3368-4A97-9C69-11FF4AC99D68Q36380600-68DEFE76-CC54-493E-AD68-52A6ACD1954EQ36708968-09544BAE-8FEF-4AF2-8A84-9F415C9C0A70Q36833723-45021198-54A5-42CC-9DF4-041C31C75AB1Q37020513-C9599B44-5FFB-4240-A971-056206FC1654Q37125137-A07175EA-1B8B-454D-836B-9379A828FFBEQ37158037-FE44F918-95F2-446A-934B-7F30BB564458
P2860
Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tuberculosis in antiretroviral ...... es of screening and diagnosis.
@ast
Tuberculosis in antiretroviral ...... es of screening and diagnosis.
@en
type
label
Tuberculosis in antiretroviral ...... es of screening and diagnosis.
@ast
Tuberculosis in antiretroviral ...... es of screening and diagnosis.
@en
prefLabel
Tuberculosis in antiretroviral ...... es of screening and diagnosis.
@ast
Tuberculosis in antiretroviral ...... es of screening and diagnosis.
@en
P2860
P921
P356
P1476
Tuberculosis in antiretroviral ...... es of screening and diagnosis.
@en
P2860
P304
P356
10.1093/INFDIS/JIR411
P407
P478
204 Suppl 4
P5008
P577
2011-11-01T00:00:00Z
2011-11-15T00:00:00Z